Drug
Olezarsen Sodium
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Blood Triglycerides Increased | 63 | 110.6 | 121.9 | signal |
| 2 | Injection Site Discolouration | 16 | 40.1 | 41.0 | signal |
| 3 | Pancreatitis Acute | 26 | 36.2 | 37.6 | signal |
| 4 | Injection Site Rash | 20 | 20.5 | 21.0 | signal |
| 5 | Injection Site Urticaria | 13 | 16.6 | 16.9 | signal |
| 6 | Glycosylated Haemoglobin Increased | 13 | 16.0 | 16.3 | signal |
| 7 | Injection Site Irritation | 6 | 14.7 | 14.8 | signal |
| 8 | Pancreatitis | 25 | 14.7 | 15.2 | signal |
| 9 | Injection Site Erythema | 51 | 12.8 | 13.8 | signal |
| 10 | Injection Site Pruritus | 22 | 10.3 | 10.6 | signal |
| 11 | Injection Site Swelling | 24 | 9.8 | 10.2 | signal |
| 12 | Injection Site Induration | 4 | 9.6 | 9.6 | signal |
| 13 | Injection Site Nodule | 3 | 8.5 | 8.5 | signal |
| 14 | Injection Site Bruising | 21 | 8.3 | 8.5 | signal |
| 15 | Injection Site Pain | 59 | 6.0 | 6.5 | signal |
| 16 | Injection Site Warmth | 3 | 4.5 | 4.5 | signal |
| 17 | Injection Site Mass | 5 | 4.2 | 4.2 | signal |
| 18 | Injection Site Haemorrhage | 8 | 3.1 | 3.2 | signal |